States Offering Broad GLP-1 Coverage for Obesity: A total of 14 states, including California, Michigan, and Pennsylvania, provide Medicaid coverage for the most common GLP-1s approved for either Type 2 diabetes or obesity
However, it may take several years for these savings to offset initial spending increases
And the reason why theyre so effective is because they mimic a hormone in the body called GLP-1, glucagonlike peptide 1fun name
Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and established cardiovascular disease
Modulation is typically mild but significant in the setting of hyperprolactinemia
Dorr R.T., Lines R., Levine N., et al